Invida joins hands with Roche Korea

Published: 2011-02-17 06:57:00

Updated: 2011-02-17 06:57:00

Invida Group Pte Ltd, the leading specialty biopharmaceutical company focusing on the commercialization of healthcare products throughout Asia Pacific, Tuesday announced that it has entered into an agreement with Roche Korea to market Roche’s proprietary products in Korea.

Under this agreement, Invida will take on distribution of CNS related drugs (e.g., Madopar, Rivotril and Valium) includi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.